Evofem Biosciences (OTC: EVFM)
$0.01
(-2.0%)
-$0.00
Price as of August 29, 2025, 2:51 p.m. ET
Evofem Biosciences Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
Evofem Biosciences Company Info
Evofem Biosciences, Inc. is a commercial-stage biopharmaceutical company, which develops and commercializes innovative products to unmet needs in women's sexual and reproductive health. Its product includes Phexxi (lactic acid, citric acid and potassium bitartrate), a hormone-free vaginal gel and EVO100, an investigational drug, which is used for urogenital Chlamydia trachomatis and Neisseria gonorrhoeae infection in women. The company was founded in 2007 and is headquartered in San Diego, CA.
News & Analysis
Featured Article
Evofem Revenue Jumps 16 Percent in Q2
Motley Fool Markets Team | Aug 14, 2025
Featured Article
Why Evofem Biosciences Stock Is Falling Today
The company's performance during the fourth quarter was short of expectations.
Prosper Junior Bakiny | Mar 5, 2021
Valuation
Related Stocks
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.